The Innovative Medicines for Luxembourg Asbl (IML) represents the research-based pharmaceutical industry in Luxembourg. As the voice of the sector, IML fosters a healthcare environment that promotes therapeutic innovation and ensures that patients benefi t from the latest medical advances. Engaging with national and European stakeholders, IML advocates for policies that support pharmaceutical research, market access, and a strong healthcare ecosystem. By facilitating dialogue between industry, policymakers, and healthcare professionals, IML contributes to shaping a dynamic and innovation-driven pharmaceutical landscape in Luxembourg, ensuring sustainable access to cutting-edge treatments.